BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 30154114)

  • 21. Unresolved issues in hematopoietic stem cell transplantation for severe combined immunodeficiency: need for safer conditioning and reduced late effects.
    Horn B; Cowan MJ
    J Allergy Clin Immunol; 2013 May; 131(5):1306-11. PubMed ID: 23622119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD4+ T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validation.
    de Koning C; Prockop S; van Roessel I; Kernan N; Klein E; Langenhorst J; Szanto C; Belderbos M; Bierings M; Boulad F; Bresters D; Cancio M; Curran K; Kollen W; O'Reilly R; Scaradavou A; Spitzer B; Versluijs B; Huitema A; Lindemans C; Nierkens S; Boelens JJ
    Blood; 2021 Feb; 137(6):848-855. PubMed ID: 33150379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC.
    Cuvelier GDE; Logan BR; Prockop SE; Buckley RH; Kuo CY; Griffith LM; Liu X; Yip A; Hershfield MS; Ayoub PG; Moore TB; Dorsey MJ; O'Reilly RJ; Kapoor N; Pai SY; Kapadia M; Ebens CL; Forbes Satter LR; Burroughs LM; Petrovic A; Chellapandian D; Heimall J; Shyr DC; Rayes A; Bednarski JJ; Chandra S; Chandrakasan S; Gillio AP; Madden L; Quigg TC; Caywood EH; Dávila Saldaña BJ; DeSantes K; Eissa H; Goldman FD; Rozmus J; Shah AJ; Vander Lugt MT; Thakar MS; Parrott RE; Martinez C; Leiding JW; Torgerson TR; Pulsipher MA; Notarangelo LD; Cowan MJ; Dvorak CC; Haddad E; Puck JM; Kohn DB
    Blood; 2022 Aug; 140(7):685-705. PubMed ID: 35671392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hematopoietic Cell Transplantation for Severe Combined Immunodeficiency Patients: a Japanese Retrospective Study.
    Miyamoto S; Umeda K; Kurata M; Nishimura A; Yanagimachi M; Ishimura M; Sato M; Shigemura T; Kato M; Sasahara Y; Iguchi A; Koike T; Takahashi Y; Kajiwara M; Inoue M; Hashii Y; Yabe H; Kato K; Atsuta Y; Imai K; Morio T
    J Clin Immunol; 2021 Nov; 41(8):1865-1877. PubMed ID: 34448087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hematopoietic cell transplantation for treatment of primary immune deficiencies.
    Burroughs L; Woolfrey A
    Cell Ther Transplant; 2010 Aug; 2(8):. PubMed ID: 21152385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem Cell Transplantation: An Ancillary Analysis of a Randomized Controlled Trial Comparing Tacrolimus/Sirolimus and Tacrolimus/Methotrexate (Blood and Marrow Transplant Clinical Trials Network/BMT CTN 0402).
    Gooptu M; Kim HT; Howard A; Choi SW; Soiffer RJ; Antin JH; Ritz J; Cutler CS
    Biol Blood Marrow Transplant; 2019 Nov; 25(11):2143-2151. PubMed ID: 31271885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conditioning regimens for inborn errors of immunity: current perspectives and future strategies.
    Nishimura A; Miyamoto S; Imai K; Morio T
    Int J Hematol; 2022 Jul; 116(1):7-15. PubMed ID: 35675025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B-cell differentiation and IL-21 response in
    Miggelbrink AM; Logan BR; Buckley RH; Parrott RE; Dvorak CC; Kapoor N; Abdel-Azim H; Prockop SE; Shyr D; Decaluwe H; Hanson IC; Gillio A; Dávila Saldaña BJ; Eibel H; Hopkins G; Walter JE; Whangbo JS; Kohn DB; Puck JM; Cowan MJ; Griffith LM; Haddad E; O'Reilly RJ; Notarangelo LD; Pai SY
    Blood; 2018 Jun; 131(26):2967-2977. PubMed ID: 29728406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report.
    Burroughs LM; Petrovic A; Brazauskas R; Liu X; Griffith LM; Ochs HD; Bleesing JJ; Edwards S; Dvorak CC; Chaudhury S; Prockop SE; Quinones R; Goldman FD; Quigg TC; Chandrakasan S; Smith AR; Parikh S; Dávila Saldaña BJ; Thakar MS; Phelan R; Shenoy S; Forbes LR; Martinez C; Chellapandian D; Shereck E; Miller HK; Kapoor N; Barnum JL; Chong H; Shyr DC; Chen K; Abu-Arja R; Shah AJ; Weinacht KG; Moore TB; Joshi A; DeSantes KB; Gillio AP; Cuvelier GDE; Keller MD; Rozmus J; Torgerson T; Pulsipher MA; Haddad E; Sullivan KE; Logan BR; Kohn DB; Puck JM; Notarangelo LD; Pai SY; Rawlings DJ; Cowan MJ
    Blood; 2020 Jun; 135(23):2094-2105. PubMed ID: 32268350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hematopoietic cell transplantation in severe combined immunodeficiency: The SCETIDE 2006-2014 European cohort.
    Lankester AC; Neven B; Mahlaoui N; von Asmuth EGJ; Courteille V; Alligon M; Albert MH; Serra IB; Bader P; Balashov D; Beier R; Bertrand Y; Blanche S; Bordon V; Bredius RG; Cant A; Cavazzana M; Diaz-de-Heredia C; Dogu F; Ehlert K; Entz-Werle N; Fasth A; Ferrua F; Ferster A; Formankova R; Friedrich W; Gonzalez-Vicent M; Gozdzik J; Güngör T; Hoenig M; Ikinciogullari A; Kalwak K; Kansoy S; Kupesiz A; Lanfranchi A; Lindemans CA; Meisel R; Michel G; Miranda NAA; Moraleda J; Moshous D; Pichler H; Rao K; Sedlacek P; Slatter M; Soncini E; Speckmann C; Sundin M; Toren A; Vettenranta K; Worth A; Yeşilipek MA; Zecca M; Porta F; Schulz A; Veys P; Fischer A; Gennery AR
    J Allergy Clin Immunol; 2022 May; 149(5):1744-1754.e8. PubMed ID: 34718043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary Immune Deficiency Treatment Consortium (PIDTC) report.
    Griffith LM; Cowan MJ; Notarangelo LD; Kohn DB; Puck JM; Pai SY; Ballard B; Bauer SC; Bleesing JJ; Boyle M; Brower A; Buckley RH; van der Burg M; Burroughs LM; Candotti F; Cant AJ; Chatila T; Cunningham-Rundles C; Dinauer MC; Dvorak CC; Filipovich AH; Fleisher TA; Bobby Gaspar H; Gungor T; Haddad E; Hovermale E; Huang F; Hurley A; Hurley M; Iyengar S; Kang EM; Logan BR; Long-Boyle JR; Malech HL; McGhee SA; Modell F; Modell V; Ochs HD; O'Reilly RJ; Parkman R; Rawlings DJ; Routes JM; Shearer WT; Small TN; Smith H; Sullivan KE; Szabolcs P; Thrasher A; Torgerson TR; Veys P; Weinberg K; Zuniga-Pflucker JC;
    J Allergy Clin Immunol; 2014 Feb; 133(2):335-47. PubMed ID: 24139498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study.
    Eissa H; Thakar MS; Shah AJ; Logan BR; Griffith LM; Dong H; Parrott RE; O'Reilly RJ; Dara J; Kapoor N; Forbes Satter L; Chandra S; Kapadia M; Chandrakasan S; Knutsen A; Jyonouchi SC; Molinari L; Rayes A; Ebens CL; Teira P; Dávila Saldaña BJ; Burroughs LM; Chaudhury S; Chellapandian D; Gillio AP; Goldman F; Malech HL; DeSantes K; Cuvelier GDE; Rozmus J; Quinones R; Yu LC; Broglie L; Aquino V; Shereck E; Moore TB; Vander Lugt MT; Mousallem TI; Oved JH; Dorsey M; Abdel-Azim H; Martinez C; Bleesing JH; Prockop S; Kohn DB; Bednarski JJ; Leiding J; Marsh RA; Torgerson T; Notarangelo LD; Pai SY; Pulsipher MA; Puck JM; Dvorak CC; Haddad E; Buckley RH; Cowan MJ; Heimall J
    J Allergy Clin Immunol; 2024 Jan; 153(1):287-296. PubMed ID: 37793572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 Definitions.
    Dvorak CC; Haddad E; Heimall J; Dunn E; Buckley RH; Kohn DB; Cowan MJ; Pai SY; Griffith LM; Cuvelier GDE; Eissa H; Shah AJ; O'Reilly RJ; Pulsipher MA; Wright NAM; Abraham RS; Satter LF; Notarangelo LD; Puck JM
    J Allergy Clin Immunol; 2023 Feb; 151(2):539-546. PubMed ID: 36456361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune Reconstitution Profiling Suggests Antiviral Protection after Transplantation with Omidubicel: A Phase 3 Substudy.
    Szabolcs P; Mazor RD; Yackoubov D; Levy S; Stiff P; Rezvani A; Hanna R; Wagner J; Keating A; Lindemans CA; Karras N; McGuirk J; Hamerschlak N; López-Torija I; Sanz G; Valcarcel D; Horwitz ME
    Transplant Cell Ther; 2023 Aug; 29(8):517.e1-517.e12. PubMed ID: 37120136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune reconstitution after anti-thymocyte globulin-conditioned hematopoietic cell transplantation.
    Bosch M; Dhadda M; Hoegh-Petersen M; Liu Y; Hagel LM; Podgorny P; Ugarte-Torres A; Khan FM; Luider J; Auer-Grzesiak I; Mansoor A; Russell JA; Daly A; Stewart DA; Maloney D; Boeckh M; Storek J
    Cytotherapy; 2012 Nov; 14(10):1258-75. PubMed ID: 22985195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hematopoietic Cell Transplantation with Reduced Intensity Conditioning Using Fludarabine/Busulfan or Fludarabine/Melphalan for Primary Immunodeficiency Diseases.
    Nishimura A; Aoki Y; Ishiwata Y; Ichimura T; Ueyama J; Kawahara Y; Tomoda T; Inoue M; Matsumoto K; Inoue K; Hiroki H; Ono S; Yamashita M; Okano T; Tanaka-Kubota M; Ashiarai M; Miyamoto S; Miyawaki R; Yamagishi C; Tezuka M; Okawa T; Hoshino A; Endo A; Yasuhara M; Kamiya T; Mitsuiki N; Ono T; Isoda T; Yanagimachi M; Tomizawa D; Nagasawa M; Mizutani S; Kajiwara M; Takagi M; Kanegane H; Imai K; Morio T
    J Clin Immunol; 2021 Jul; 41(5):944-957. PubMed ID: 33527309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis.
    Admiraal R; van Kesteren C; Jol-van der Zijde CM; Lankester AC; Bierings MB; Egberts TC; van Tol MJ; Knibbe CA; Bredius RG; Boelens JJ
    Lancet Haematol; 2015 May; 2(5):e194-203. PubMed ID: 26688094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival.
    Myers LA; Patel DD; Puck JM; Buckley RH
    Blood; 2002 Feb; 99(3):872-8. PubMed ID: 11806989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematopoietic Cell Transplantation for Inborn Errors of Immunity Other than Severe Combined Immunodeficiency in Japan: Retrospective Analysis for 1985-2016.
    Miyamoto S; Umeda K; Kurata M; Yanagimachi M; Iguchi A; Sasahara Y; Okada K; Koike T; Tanoshima R; Ishimura M; Yamada M; Sato M; Takahashi Y; Kajiwara M; Kawaguchi H; Inoue M; Hashii Y; Yabe H; Kato K; Atsuta Y; Imai K; Morio T
    J Clin Immunol; 2022 Apr; 42(3):529-545. PubMed ID: 34981329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions.
    Dvorak CC; Haddad E; Heimall J; Dunn E; Cowan MJ; Pai SY; Kapoor N; Satter LF; Buckley RH; O'Reilly RJ; Chandra S; Bednarski JJ; Williams O; Rayes A; Moore TB; Ebens CL; Davila Saldana BJ; Petrovic A; Chellapandian D; Cuvelier GDE; Vander Lugt MT; Caywood EH; Chandrakasan S; Eissa H; Goldman FD; Shereck E; Aquino VM; Desantes KB; Madden LM; Miller HK; Yu L; Broglie L; Gillio A; Shah AJ; Knutsen AP; Andolina JP; Joshi AY; Szabolcs P; Kapadia M; Martinez CA; Parrot RE; Sullivan KE; Prockop SE; Abraham RS; Thakar MS; Leiding JW; Kohn DB; Pulsipher MA; Griffith LM; Notarangelo LD; Puck JM
    J Allergy Clin Immunol; 2023 Feb; 151(2):547-555.e5. PubMed ID: 36456360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.